One year findings from Phase I/II clinical study support the feasibility of transplanting stem-cell derived dopamine progenitor cells into the brain of Parkinson’s disease patients. The post Stem Cell Therapy Shows Promise in First Human Parkinson’s Disease Trial appeared first on GEN – Genetic Engineering and Biotechnology News.
You may also like
StockWatch: Insilico Projects Profit, Revenue Leaps as...
[Podcast] From Protocol to Patient: Inside Clinical...
KKR-backed Allyntra debuts to serve medtech industry...
IHealthScreen nabs FDA nod for AI-backed dx to spot...
‘How did they get there first?’ Biotechs forced to...
Deals, deals, deals; Biohaven takes on Eli Lilly; and...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.